cyanidin-3-o-beta-glucopyranoside has been researched along with Diabetic-Retinopathy* in 2 studies
2 other study(ies) available for cyanidin-3-o-beta-glucopyranoside and Diabetic-Retinopathy
Article | Year |
---|---|
Cyanidin-3-o-glucoside (C3G) inhibits vascular leakage regulated by microglial activation in early diabetic retinopathy and neovascularization in advanced diabetic retinopathy.
Topics: Animals; Anthocyanins; Cell Line; Cell Movement; Diabetic Retinopathy; Endothelial Cells; Humans; Inflammation; Mice; Mice, Inbred C57BL; Microglia; Neovascularization, Pathologic; RNA, Messenger | 2021 |
Cyanidin-3-
Topics: Animals; Anthocyanins; Apoptosis; Cataract; Cyclooxygenase 2; Diabetic Retinopathy; Epithelial Cells; Gene Expression Regulation; Glucose; Humans; Lens, Crystalline; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction | 2020 |